Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to “False” Decreases in Renal Function-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to “False” Decreases in Renal Function

Published:2024-01 Issue:1 Volume:19 Page:153-159
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Chen Monica F.,Harada Guilherme,Liu Dazhi,DeMatteo Ray,Falcon Christina,Wilhelm Clare,Kris Mark G.,Drilon Alexander,Gutgarts Victoria

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. Transporters affecting biochemical test results: creatinine-drug interactions;Chu;Clin Pharmacol Ther,2016

2. A new equation to estimate glomerular filtration rate;Levey;Ann Intern Med,2009

3. Trimethoprim, creatinine and creatinine-based equations;Delanaye;Nephron Clin Pract,2011

4. Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion;Imamura;Clin Pharmacol Ther,2011

5. Imatinib increases serum creatinine by inhibiting its tubular secretion in a reversible fashion in chronic myeloid leukemia;Vidal-Petiot;Clin Lymphoma Myeloma Leuk,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future;Drugs;2024-07-13

2. Nephrotoxicity of targeted therapy used to treat lung cancer;Frontiers in Immunology;2024-07-04

3. Assessment of GFR in Patients with Cancer Part 2;Clinical Journal of the American Society of Nephrology;2024-06-07

4. Cancer drugs and acute kidney injury: new therapies and new challenges;Current Opinion in Nephrology & Hypertension;2024-05-07

5. Pharmacotherapy considerations in patients who develop acute kidney injury during anti-cancer therapy;Expert Opinion on Pharmacotherapy;2024-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3